Our Expertise

From evidence to real-world impact.

We offer an integrated set of services to support the full lifecycle of cancer medicines in older adults, from development to access.

Generate regulatory-grade real-world evidence to support label expansion, pricing and access strategies.

Design and deliver clinical trials for older adults, from early to late phase, in real-world and hybrid settings.

Optimise development, evidence and lifecycle strategy to maximise patient access and value.

Use fit-for-purpose AI-enabled approaches, with expert oversight, to turn complex oncology data into faster, decision-ready evidence.